Enjoy complimentary customisation on priority with our Enterprise License!
The single-use bioprocessing system market share is expected to increase by USD 10.60 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 17.33%.
The market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. The market has been broadly categorized into the following demographic segmentation by application (mAb production, vaccine production, plant cell cultivation, PSCTs, and others), end-user (pharmaceutical companies, CROs and CMOs, biotechnology companies, and Academic and research institutions), product (bags and mixers, bioreactors and fermenters, filtration devices and sampling systems, bioprocess containers, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)).
The single-use bioprocessing system market report offers information on several market vendors, including 3M Corp., ABEC Inc., Adolf Kuhner AG, Advanced Microdevices Pvt. Ltd., Avantor Inc., Celltainer, Compagnie de Saint Gobain SA, Corning Inc., Danaher Corp., Entegris Inc., Eppendorf AG, Getinge AB, Meissner Filtration Products Inc., Merck KGaA, Parker Hannifin Corp., Sartorius AG, SENTINEL PROCESS SYSTEMS INC., Solaris Biotechnology Srl, and Thermo Fisher Scientific Inc. among others.
3M Corp. - The company is publicly held and headquartered in the US. It is a global company generating USD 35,355 million in revenues and has around 95,000 employees. Its revenue from the global market contributes to its overall revenues and other offerings, but it is not a key revenue stream for the company. The company offers a single-use bioprocessing system that includes recombinant proteins that simplify the process and enhance biological drug recovery which leads to improved process economics.
Get the Single-use Bioprocessing System Market Size Forecast by Download Report Sample
Technavio categorizes the global single-use bioprocessing system market as a part of the global life science tools and services market. ?Our research report extensively covers external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the market during the forecast period.
Based on our research output, there has been a neutral impact on the market growth during and post-COVID-19 era. The increasing use of single-use technologies to minimize the risk of contamination is notably driving the market growth, although factors such as issues related to extractables and leachable in polymeric systems may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Single-use Bioprocessing System Market Driver
One of the key factors driving the global single-use bioprocessing system industry growth is the increasing use of single-use technologies to minimize the risk of contamination. Contamination among batches reduces the production yield and increases the cost and time-to-market by making it necessary to undertake additional steps for purification. In addition, the detection of impurities in the post-commercial stages by regulatory bodies can make end-users liable for product recalls and legal actions. For instance, in July 2018, the US FDA announced a series of voluntary recalls for products containing valsartan due to their contamination with a possible carcinogenic compound, N-nitroso dimethylamine (NDMA). Thus, factors like these and the stringent regulations by regulatory authorities such as the US FDA, EMA, and China Food and Drug Administration (CFDA) will boost the demand for advanced technologies, such as SUB systems in the forecast period.
Key Single-use Bioprocessing System Market Trend
The rising focus of market vendors on strategic partnerships is one of the key single-use bioprocessing (SUB) system market trends that is expected to impact the industry positively in the forecast period. Strategic partnership agreements with suppliers, other private vendors, and end-users will help vendors to improve their understanding of market demand and enhance their product portfolios. For instance, in September 2020, Humanigen, Inc announced a strategic collaboration with Thermo Fisher Scientific to expand its manufacturing capacity for Lenzilumab, which is in the Phase 3 registration study for patients infected by COVID-19, to support a potential Emergency Use Authorization (EUA). Such partnership agreements will allow vendors to enhance their product offerings and increase the accessibility of their products in the coming years.
Key Single-use Bioprocessing System Market Challenge
One of the key challenges to the global SUB system industry growth is the issues related to extractables and leachable in polymeric systems. Leachables can have a toxic effect on patients who consume these drugs and can also have an adverse impact on the properties of drugs, thereby reducing their efficacy. Due to contamination concerns, the US FDA has mandated that pharmaceutical companies must demonstrate the safety of the materials used in container production systems, closure systems, and drug delivery devices. Furthermore, vendors need to ensure the safety of materials used in manufacturing SUB systems by endorsing their biological compatibility through various test standards, such as USP <661> and USP <87>. All these factors may adversely impact the growth of the global market in the forecast period.
This market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
The parent, global life science tools and services market covers products and companies engaged in R&D of a variety of product categories, including capital equipment, instruments, accessories, and consumables that are used for R&D on pharmaceuticals and bioprocess technology products and laboratory diagnosis of various diseases. It also covers life sciences-related services, including contract research, contract manufacturing, and contract sales.
Our In-house experts produce extensive information on the value chain and parent market of the single-use bioprocessing system market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profit and also optimization and evaluation of business strategies. The players across the value chain include selective data and analysis from entire research findings as per the scope of the report.
Get a glance at the market share of various regions Request PDF sample now!
37% of the market's growth will originate from North America during the forecast period. The US is the key market for single-use bioprocessing systems in North America. However, market growth in this region will be slower than the growth of the market in other regions.
The significant increase in the adoption of SUB systems among pharmaceutical companies to achieve lower costs and higher productivity, as well as strategic enhancements in the therapeutic approval process and the presence of key players will facilitate the market growth in North America over the forecast period. Some of the key vendors in the region are Danaher, General Electric, Thermo Fisher Scientific, Avantor, W. L. Gore and Associates Inc. (W. L. Gore and Associates), ABEC Inc. (ABEC), and PBS Biotech Inc. (PBS Biotech).
This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The outbreak of COVID-19 has adversely affected nearly all global industries, with the biopharmaceutical and bioprocessing industries being an exception. Several big pharma and biotech companies in the region are pursuing vaccine production, which has led to an increase in the demand for SUB systems in the region. Moreover, in 2021, the regional governments such as the US, Canada, and others, in this region initiated the 1st phase of the vaccination program and lifted the lockdown and travel restrictions, which boosted the demand for the vaccine as the government in this region announced vaccination for all age groups. Therefore, such factors are expected to increase the growth of the market in the regional market during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The single-use bioprocessing system market share growth by the mAb production segment will be significant during the forecast period. SUB systems eradicate the chances of cross-contamination and reduce the time involved in the preparation of new equipment between mAb production batches. The need to achieve low-cost and flexible production capabilities will compel mAb manufacturers to deploy single-use technologies in purification operations, which involve the significant use of single-use filters, which will support the market growth through this segment in the forecast years.
This report provides an accurate prediction of the contribution of all the segments to the growth of the market size and actionable market insights on the post-COVID-19 impact on each segment.
Single-use Bioprocessing System Market Scope |
|
Report Coverage |
Details |
Page number |
189 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 17.33% |
Market growth 2022-2026 |
$ 10.60 billion |
Market structure |
Fragmented |
YoY growth (%) |
14.56 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key consumer countries |
US, Germany, France, China, and Japan |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
3M Corp., ABEC Inc., Adolf Kuhner AG, Advanced Microdevices Pvt. Ltd., Avantor Inc., Celltainer, Compagnie de Saint Gobain SA, Corning Inc., Danaher Corp., Entegris Inc., Eppendorf AG, Getinge AB, Meissner Filtration Products Inc., Merck KGaA, Parker Hannifin Corp., Sartorius AG, SENTINEL PROCESS SYSTEMS INC., Solaris Biotechnology Srl, and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.